Clinical trial shows benefit to adding avastin to neoadjuvant chemotherapy in breast cancer patients

Amid the controversy surrounding the Food and Drug Administration's ruling that Avastin should no longer be used to treat metastatic breast cancer, a new multinational Phase III clinical trial shows that Avastin significantly increased tumor response rates in breast cancer patients when given before surgery.

Read the whole article on Physorg

More from Physorg